<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Yestino - The Signal · Forget GLP-1</title><link>https://yestino.com/entities/forget-glp-1-bf37db</link><description>Every event involving Forget GLP-1</description><language>en</language><atom:link href="https://yestino.com/entities/forget-glp-1-bf37db/feed.xml" rel="self" type="application/rss+xml"/><item><title>Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine</title><link>https://yestino.com/events/forget-glp-1-stocks-baldness-drugs-are-wall-street-s-next-go-73d9d2</link><guid isPermaLink="true">https://yestino.com/events/forget-glp-1-stocks-baldness-drugs-are-wall-street-s-next-go-73d9d2</guid><pubDate>Sat, 29 Aug 2026 15:11:36 GMT</pubDate><description>Pattern hair loss affects an estimated 50 million men and 30 million women in the US, but there have been no new approved drugs since the late 1990s.
Sources: Fortune</description></item></channel></rss>